Langerhans-Cell Histiocytosis
Langerhans-Cell Histiocytosis
About this item
Full title
Langerhans-Cell Histiocytosis
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
The New England journal of medicine, 2018-08, Vol.379 (9), p.856-868
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
A spectrum of diseases formerly known as histiocytosis X and now called Langerhans-cell histiocytosis is characterized by ERK pathway activation (including
BRAF
V600E mutations) and diverse clinical manifestations involving bone, skin, lung, and pituitary.
Alternative Titles
Full title
Langerhans-Cell Histiocytosis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6334777
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6334777
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMra1607548
